November 14, 2017 GLG Life Tech Corporation Reports 2017 Third Quarter Financial Results
November 9, 2017 GLG Announces Completion of Major Milestone with Registration of Joint Stock Company; Provides Update on Phase 2 Debt Restructure
September 26, 2017 GLG Life Tech Corporation Announces Breakthrough Development of Super RA Seed
September 21, 2017 GLG Life Tech Corporation Announces Major Developments In High Reb M Stevia Plants and Product Innovations
Aug 14, 2017 GLG Life Tech Corporation Reports 2017 Second Quarter Financial Results
May 29, 2017 GLG Life Tech Corporation Announces 2017 AGM Voting Results
May 12, 2017 GLG Life Tech Coporation Reports 2017 First Quarter Financial Results
April 24, 2017 AGM and Debt Restructuring
March 31, 2017 GLG Announces 2016 Annual & Fourth Quarter Financial Results

Annual Consolidated Financial Statements 2015
Annual Management Discussion and Analysis 2015
Annual Information Form 2015
Consolidated Financial Statements Third Quarter 2015
Management Discussion and Analysis Third Quarter 2015
Consolidated Financial Statements Second Quarter 2015
Management Discussion and Analysis Second Quarter 2015
Consolidated Financial Statements First Quarter 2015
Management Discussion and Analysis First Quarter 2015

Annual Consolidated Financial Statements 2014
Annual Management Discussion and Analysis 2014 – Amended and Restated
Annual Information Form 2014
Consolidated Financial Statements Third Quarter 2014
Management Discussion and Analysis Third Quarter 2014
Consolidated Financial Statements Second Quarter 2014
Management Discussion and Analysis Second Quarter 2014
Consolidated Financial Statements First Quarter 2014
Management Discussion and Analysis First Quarter 2014

Annual Consolidated Financial Statements 2013
Annual Management Discussion and Analysis 2013
Annual Information Form 2013
Consolidated Financial Statements Third Quarter 2013
Management Discussion and Analysis Third Quarter 2013
Consolidated Financial Statements Second Quarter 2013
Management Discussion and Analysis Second Quarter 2013
Consolidated Financial Statements First Quarter 2013
Management Discussion and Analysis First Quarter 2013

Consolidated Financial Statements Years Ended 2012 and 2011
Management Discussion and Analysis Fourth Quarter 2012
Annual Information Form 2012
Consolidated Financial Statements Third Quarter 2012
Management Discussion and Analysis Third Quarter 2012
Consolidated Financial Statements Second Quarter 2012
Management Discussion and Analysis Second Quarter 2012
Consolidated Financial Statements First Quarter 2012
Management Discussion and Analysis First Quarter 2012

Consolidated Financial Statements Years Ended 2010 and 2011
Management Discussion and Analysis Fourth Quarter 2011
Annual Information Form 2011
Consolidated Financial Statements Third Quarter 2011
Management Discussion and Analysis Third Quarter 2011
Consolidated Financial Statements Second Quarter 2011
Management Discussion and Analysis Second Quarter 2011
Consolidated Financial Statements First Quarter 2011
Management Discussion and Analysis First Quarter 2011

Dr. Luke Zhang, Chairman and Chief Executive Officer

With over 30 years of experience, Dr. Luke Zhang is a recognized individual in the business, medical and academic communities in both North America and Asia. He has successfully built and managed a number of firms in the health industry, food industry, medical equipment and software development industries.

He holds a Ph. D. in Pharmacology from Vanderbilt University in the United States, a Masters of Science in Pharmaceutical Chemistry from Shanghai First Medical University in China and a Bachelor of Medicine from Shandong Medical University in China.

His expertise in the medical field have helped fuel company growth as well as set foundational principals in research and innovation. In addition, his vision and strategic direction have enabled the company to maintain a leading edge in the global community.

Brian Palmieri, Vice Chairman

Brian Palmieri is a hands-on executive with extensive international business experience. As principal and CEO of multiple ventures, he has successfully built global corporations in manufacturing, services, and importing/exporting. He particularly specializes in start up and company restructuring, focusing on long term growth plans and profitability.

His aggressive entrepreneurship over the last 25 years has led him to all regions of the world including Europe, Asia, Africa and the Middle East. He has expertise in business development, operations, acquisitions, strategic alliances, and financing.

Currently, he is positioning GLG for global growth into markets outside of Asia.

Dr. Hong Zhao Guang, Independent Director

Dr. Hong Zhao Guang is an active leader in both the academic and business communities in China. Receiving his degree from Shanghai First Medical College, he has been the vice president of Beijing Anzhen Hospital and the vice director of the Cardiovascular Disease Expert Consulting Committee for the Ministry of Public Health in China. Currently Dr. Hong is directing commissioner with the Aged Chinese Healthcare Association and the vice group leader for physicians at Capital Medical Science University, one of the top ranking academic medical institutions in China.

Dr. Hong has written and edited more than ten books and published more than one hundred academic theses and five hundred articles for the scientific community. During the last 15 years, Dr. Hong has devoted his time to the education of citizens throughout China on the importance of wellness, health, and an active lifestyle, including the prevention of diabetes and cardiovascular diseases. His books have been read by more than 70 million people and his lectures heard by over 200 million people in China.

Fangzhen He, Independent Director

Mr. Fangzhen He is a specialist in manufacturing and production. With over 40 years of experience, his rich expertise as a chief engineer lies in optimizing manufacturing plant and personnel, particularly in China. His specialties include planning, operational structure, maintenance, safety, quality control and risk management as well as the assignment, training and supervision of production and technology personnel. Mr. He graduated from Taiyuan Polytech University in China.

Paul Block, Independent Director

Mr. Block brings to GLG’s Board a wealth of senior executive experience in the global food and beverage and high intensity sweetener industries, particularly in the areas of sales, marketing, and business development.

Most recently, Mr. Block served as Chief Executive Officer of Merisant Worldwide Company, Inc. and the Whole Earth Sweetener Co., LLC. While at Merisant, Mr. Block oversaw the company’s well-recognized line of sweeteners, including the Equal® sweetener brand. Prior to joining Merisant, Mr. Block held C-level positions at Sara Lee Coffee and Tea Consumer Brands, Allied Domecq Spirits USA and Groupe Danone. Mr. Block has been a key figure in developing the global stevia tabletop market through his role as CEO at Merisant and the Whole Earth Sweetener Co., LLC., launching the successful Pure Via® line of tabletop zero calorie stevia sweeteners.

Mr. Block’s knowledge, experience, and strategic skills with respect to stevia and high intensity sweeteners are a valuable asset for GLG.

Madame Sophia Leung, C.M. has made significant contributions to the business and political communities in Canada. Her various awards and achievements have reached the provincial as well as national level. Additionally, she has played an active role in the international business community, specifically in China, and has in turn also received international honors. The following is an overview of her accomplishments:

• Special Advisor to Prime Minister of Canada in International Trade 2004-2006
• Honorary President, Shenzhen Chamber of International Investment and Financing 2006-2008
• Parliamentary Secretary for National Revenue of Canada 2000-2004
• Member of Parliament of Canada 1997–2004
• Chair, British Columbia Liberal Caucus
• Chair, Northern and Western Liberal Caucus
• Member, Standing Committee of Finance/Citizenship and Immigration in Parliament
• Founding Chair, the Canada- Hong Kong Parliamentary Friendship Group
• Vice-Chair, the Canada-China Legislative Friendship Association
• YWCA Women of Distinction
• Canada Volunteer Award
• Order of Canada
• Queen Elizabeth II Golden Jubilee Medal
• Prime Minister’s Citation

Ms. Liu Yingchun has extensive experience in finance and accounting. Her most recently held positions include Credit Director for the Heze Industrial and Commercial Bank and Division Director for Pacific Life Insurance in Heze, China.